Trials / Sponsors / TIDHI Innovation Inc.
TIDHI Innovation Inc.
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT- Inflammatory Bowel Disease (IBD), Crohn Disease (CD), Ulcerative Colitis (UC) | — | 2026-01-29 |
| Recruiting | TIDHI Mental Health in IBD Patients Study Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD) | N/A | 2025-07-22 |